Weifa
Template:Short description Script error: No such module "Infobox".Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for unknown parameters".
Weifa[1] is a Norwegian pharmaceutical company headquartered in Oslo with production facilities in Kragerø.
Weifa is one of the world’s largest producers of Metformin hydrochloride and a leading producer of alkaloid opiates. Production facilities follow GMP standards.
History
Weifa was founded by pharmacist Olaf Weider in 1940.[2]
Therapeutic areas
Weifa focuses on three therapeutic areas:
- Pain management
- Diabetes management
- Food supplements
Products
- bra!: Evening primrose oil.
- Bronkyl: Expectorant effervescent tablet.[3]
- Dexyl: Nasal spray.[4]
- Fanalgin: Pain reliever and fever reducer with an addition of caffeine.[5]
- Ferromax: Iron supplement.[6]
- Fluormax: Fluorine supplements.[7]
- Ibux: A brand name for ibuprofen.
- Ibux Gel: A gel version of Ibux.[8]
- Nazamér: Salt water spray.[9]
- Nazaren: Salt water nasal spray.[10]
- Paracet: A brand name for paracetamol.[11]
- Paracetduo: Similar to Paracet with the addition of caffeine for increased pain relief.[12]
- Proxan: Brand name for naproxen.[13]
- Pyrivir: Relieves symptoms of cold sores.[14]
- Samin: Symptom relief in patients with Osteoarthritis.
- Tigerbalsam: Heat rub.[15]
- Tussin: Cough medicine.[16]
- Weifa-C Nypeekstrakt: Vitamin C from rose hip extract.
- Weifa C-vitamin brusetabletter: Vitamin C effervescent tablets.
- Weifa Kalsium: Calcium supplements.
Active ingredients
- Codeine: Used in pain relievers and cough medicine.[17]
- Metformin: Used in first-line treatment of diabetes mellitus type 2.[18]
- Pholcodine: Used in cough medicine.[17]
Development
With a total of over 99 employees, Weifa is today generating an annual turnover of approximately €40 million (35% of the turnover is achieved internationally). Weifa bases its development on 3 criteria:
- International expansion
- Expertise in pharmaceuticals and fine chemicals
- Partnership agreements
Norway
Weifa has market leadership in pain management products for the Norwegian market, with a portfolio of branded products that includes established brand names such as the Ibux tablets, Paracet tablets and Paralgin Forte tablets. Branded products accounts for approximately 70% of net sales.
Export
Weifa’s leading export markets are Germany and United Kingdom. Besides these two essential export markets, Weifa has a long-standing presence in all the main countries of the European Union, in Eastern Europe, in Africa, in North America, in South America and in Asia.
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
Script error: No such module "Check for unknown parameters".